| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $989K | -66.8% |
| SG&A Expense | $7.5M | +4.8% |
| Operating Income | -$8.5M | +14.8% |
| Net Income | -$2.9M | +60.0% |
| EPS (Basic) | -$1.30 | -75.7% |
| EPS (Diluted) | -$1.30 | -75.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $183K | -43.3% |
| Current Assets | $896K | -76.3% |
| Total Assets | $1.1M | -77.2% |
| Current Liabilities | $9.3M | -52.3% |
| Stockholders' Equity | -$8.8M | +43.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.0M | +33.5% |
| Financing Cash Flow | $3.1M | -72.5% |